---
title: "Midas Pharmasec Ltd(merged) (530257) — Share Price, Financials & Analysis"
symbol: "530257"
company: "Midas Pharmasec Ltd(merged)"
canonical: "https://tapetide.com/stocks/530257"
isin: "INE113D01025"
bse_code: "530257"
generated_at: "2026-10-13T11:01:48.469Z"
---

# Midas Pharmasec Ltd(merged) (530257)

Canonical page: https://tapetide.com/stocks/530257

## Company

- **BSE Code:** 530257
- **ISIN:** INE113D01025
- **Stock Type:** DELISTED
- **Face Value:** ₹10
- **F&O Eligible:** No

## Latest Price

## Key Insights

### Strengths

- Company is almost debt free.

### Weaknesses

- Company has a low return on equity of -8.21% over last 3 years.

## Growth Rates

| Metric | 1Y | 3Y |
| --- | --- | --- |
| net income growth | 116% | 33% |
| revenue growth | 100% | -1% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2013 | Jun 2013 | Sep 2013 | Dec 2013 | Mar 2014 | Jun 2014 | Sep 2014 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 0.21 | 0.87 | 0.06 | 0.74 | 1.25 | 0 | 0 |
| Expenses | 0.17 | 0.84 | 0.03 | 0.76 | 1.35 | 0.1 | 0.11 |
| Operating Profit | 0.04 | 0.03 | 0.03 | -0.02 | -0.1 | -0.1 | -0.11 |
| OPM % | 19.05 | 3.45 | 50 | -2.7 | -8 | — | — |
| Other Income | 0.04 | 0.02 | 0.02 | 0.02 | 0.09 | 0.01 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 0.08 | 0.05 | 0.05 | 0 | -0.01 | -0.09 | -0.11 |
| Tax % | 37.5 | 40 | 40 | — | 0 | 0 | 0 |
| Net Profit | 0.05 | 0.04 | 0.04 | 0 | -0.01 | -0.09 | -0.11 |
| EPS in Rs | 0.02 | 0.02 | 0.02 | 0 | 0 | -0.04 | -0.05 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 |
| --- | --- | --- | --- | --- | --- |
| Sales | 0.22 | 0.25 | 0.01 | 0.12 | 0.24 |
| Expenses | 0.31 | 0.74 | 0.44 | 1.27 | 0.34 |
| Operating Profit | -0.09 | -0.49 | -0.43 | -1.15 | -0.1 |
| OPM % | -40.91 | -196 | -4300 | -958.33 | -41.67 |
| Other Income | 0.07 | -0.38 | 0.16 | 0 | 0.31 |
| Interest | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | -0.02 | -0.87 | -0.27 | -1.15 | 0.21 |
| Tax % | 0 | 0 | 0 | 0 | 14.29 |
| Net Profit | -0.02 | -0.87 | -0.27 | -1.15 | 0.18 |
| EPS in Rs | — | — | — | -1.98 | 0.18 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 |
| --- | --- | --- | --- | --- | --- |
| Equity Capital | 3.35 | 3.36 | 1.68 | 10 | 10 |
| Reserves | -0.56 | -1.43 | -0.02 | -1.17 | -0.99 |
| Borrowings | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 0.02 | 0.12 | 0.08 | 0.01 | 0.03 |
| Total Liabilities | 2.81 | 2.05 | 1.74 | 8.84 | 9.04 |
| Fixed Assets | 0.01 | 0.01 | 0.01 | 0 | 0 |
| CWIP | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 2.8 | 2.04 | 1.73 | 8.84 | 9.04 |
| Total Assets | 2.81 | 2.05 | 1.74 | 8.84 | 9.04 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 |
| --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | — | 0 | -0.02 | -2.84 | 1.19 |
| Cash from Investing Activity | — | 0 | 0 | 0.01 | 0 |
| Cash from Financing Activity | — | 0 | 0 | 8.28 | 0 |
| Net Cash Flow | — | 0 | -0.02 | 5.45 | 1.19 |
| Free Cash Flow | — | 0 | -0.02 | -2.84 | 1.19 |
| CFO/OP | — | 0 | 5 | 247 | -1190 |

### Ratios

| Item | Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 |
| --- | --- | --- | --- | --- | --- |
| Debtor Days | 2256.36 | 1328.6 | 32850 | 0 | 0 |
| Inventory Days | 434.52 | 1095 | 1235.38 | 438 | 0 |
| Days Payable | 17.38 | 19.21 | 0 | 0 | — |
| Cash Conversion Cycle | 2673.51 | 2404.39 | 34085.38 | 438 | 0 |
| Working Capital Days | 4396.59 | 2613.4 | 56575 | 9915.83 | 3437.08 |
| ROCE % | — | -20.34 | -19.5 | -21.73 | 2.35 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Sell
- **Buy / Neutral / Sell:** 2 / 6 / 11

### Moving Averages — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 21.1 | Buy |
| EMA (10) | 21.17 | Buy |
| SMA (20) | 21.96 | Sell |
| EMA (20) | 21.75 | Sell |
| SMA (50) | 23.5 | Sell |
| EMA (50) | 23.29 | Sell |
| SMA (100) | 25.71 | Sell |
| EMA (100) | 25.28 | Sell |
| SMA (200) | 28.65 | Sell |
| EMA (200) | 28.5 | Sell |

### Oscillators — summary: **Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 42.97 | Neutral |
| MACD (12,26,9) | -0.79 | Sell |
| Stochastic (14,3,3) | 20.55 | Neutral |
| ADX (14) | 20.04 | Neutral |
| Williams %R (14) | -64.8 | Neutral |
| ATR (14) | 1.35 | High Volatility |
| ROC (12) | -6.99 | Sell |
| Stoch RSI (14) | 89.64 | Sell |
| UO (7,14,28) | 43.8 | Neutral |

## Filings & Documents

### Annual Reports

| Date | Document |
| --- | --- |
| Mar 2014 | [Financial Year 2014](http://www.bseindia.com/bseplus/AnnualReport/519035/5190350314.pdf) |
| Mar 2013 | [Financial Year 2013](https://www.bseindia.com/bseplus/AnnualReport/519035/5190350313.pdf) |
| Mar 2012 | [Financial Year 2012](https://www.bseindia.com/bseplus/AnnualReport/519035/5190350312.PDF) |
| Mar 2011 | [Financial Year 2011](https://www.bseindia.com/bseplus/AnnualReport/519035/5190350311.pdf) |
| Mar 2010 | [Financial Year 2010](https://www.bseindia.com/bseplus/AnnualReport/519035/5190350310.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-10-13T11:01:48.469Z.